IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v121y2017i7p745-754.html
   My bibliography  Save this article

Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature

Author

Listed:
  • Aerts, Céline
  • Sunyoto, Temmy
  • Tediosi, Fabrizio
  • Sicuri, Elisa

Abstract

Pharmaceutical companies are reluctant to invest in research and development (R&D) of products for neglected tropical diseases (NTDs) mainly due to the low ability-to-pay of health insurance systems and of potential consumers. The available preventive and curative interventions for NTDs mostly rely on old technologies and products that are often not adequate. Moreover, NTDs mostly affect populations living in remote rural areas and conflict zones, thereby hampering access to healthcare. The challenges posed by NTDs have led to the proliferation of a variety of public-private partnerships (PPPs) in the last decades. We conducted a systematic review to assess the functioning and impact of these partnerships on the development of and access to better technologies for NTDs. Our systematic review revealed a clear lack of empirical assessment of PPPs: we could not find any impact evaluation analyses, while these are crucial to realize the full potential of PPPs and to progress further towards NTDs elimination.

Suggested Citation

  • Aerts, Céline & Sunyoto, Temmy & Tediosi, Fabrizio & Sicuri, Elisa, 2017. "Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature," Health Policy, Elsevier, vol. 121(7), pages 745-754.
    • Handle: RePEc:eee:hepoli:v:121:y:2017:i:7:p:745-754
    DOI: 10.1016/j.healthpol.2017.05.005
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851017301434
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2017.05.005?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Mrazek, Monique F. & Mossialos, Elias, 2003. "Stimulating pharmaceutical research and development for neglected diseases," Health Policy, Elsevier, vol. 64(1), pages 75-88, April.
    2. Jimmy Le, 2014. "Financing Sustainable Drug Development for Neglected Diseases: A Case of Push-Pull Mechanisms and Global Public Goods," The Economic and Social Review, Economic and Social Studies, vol. 45(2), pages 245-259.
    3. R. L. Juliano, 2013. "Pharmaceutical innovation and public policy: The case for a new strategy for drug discovery and development," Science and Public Policy, Oxford University Press, vol. 40(3), pages 393-405, February.
    4. Pratt, B. & Loff, B., 2013. "Linking research to global health equity: The contribution of product development partnerships to access to medicines and research capacity building," American Journal of Public Health, American Public Health Association, vol. 103(11), pages 1968-1978.
    5. De Pinho Campos, Katia & Norman, Cameron D. & Jadad, Alejandro R., 2011. "Product development public–private partnerships for public health: A systematic review using qualitative data," Social Science & Medicine, Elsevier, vol. 73(7), pages 986-994.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Nannan Wang & Minxun Ma, 2021. "Public–private partnership as a tool for sustainable development – What literatures say?," Sustainable Development, John Wiley & Sons, Ltd., vol. 29(1), pages 243-258, January.
    2. Perez, Marybel & von Schnurbein, Georg & Gehringer, Theresa, 2022. "Mitigating health policy fragmentation through interlocks. The networks between American and Swiss public-private partnerships," Health Policy, Elsevier, vol. 126(11), pages 1163-1172.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Patrícia Véras Marrone & Fabio Rampazzo Mathias & Wanderley Marques Bernardo & Marina Feliciano Orlandini & Maria Carolina Andrade Serafim & Maria Lídia Rebello Pinho Dias Scoton & Juliano Marçal Lope, 2023. "Decision Criteria for Partial Nationalization of Pharmaceutical Supply Chain: A Scoping Review," Economies, MDPI, vol. 11(1), pages 1-21, January.
    2. Mueller-Langer, Frank, 2013. "Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?," Health Economics, Policy and Law, Cambridge University Press, vol. 8(2), pages 185-208, April.
    3. Mueller-Langer, Frank, 2011. "Neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting research?," MPRA Paper 40193, University Library of Munich, Germany.
    4. Maarten J. IJzerman & Hendrik Koffijberg & Elisabeth Fenwick & Murray Krahn, 2017. "Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature," PharmacoEconomics, Springer, vol. 35(7), pages 727-740, July.
    5. Nakamura, Yusuke & Matsumoto, Hiroshige & Yamamoto-Mitani, Noriko & Suzuki, Miho & Igarashi, Ayumi, 2018. "Impact of support agreement between municipalities and convenience store chain companies on store staff’s support activities for older adults," Health Policy, Elsevier, vol. 122(12), pages 1377-1383.
    6. Nannan Wang & Minxun Ma, 2021. "Public–private partnership as a tool for sustainable development – What literatures say?," Sustainable Development, John Wiley & Sons, Ltd., vol. 29(1), pages 243-258, January.
    7. Forman, Rebecca & Azzopardi-Muscat, Natasha & Kirkby, Victoria & Lessof, Suszy & Nathan, Naomi Limaro & Pastorino, Gabriele & Permanand, Govin & van Schalkwyk, May CI & Torbica, Aleksandra & Busse, Re, 2022. "Drawing light from the pandemic: Rethinking strategies for health policy and beyond," Health Policy, Elsevier, vol. 126(1), pages 1-6.
    8. Munira, Syarifah Liza & Fritzen, Scott A., 2007. "What influences government adoption of vaccines in developing countries? A policy process analysis," Social Science & Medicine, Elsevier, vol. 65(8), pages 1751-1764, October.
    9. Srinivas, Smita, 2006. "Industrial Development and Innovation: Some Lessons from Vaccine Procurement," World Development, Elsevier, vol. 34(10), pages 1742-1764, October.
    10. Nimisha Pandey & Heleen de Coninck & Ambuj D Sagar, 2022. "Beyond technology transfer: Innovation cooperation to advance sustainable development in developing countries," Wiley Interdisciplinary Reviews: Energy and Environment, Wiley Blackwell, vol. 11(2), March.
    11. Kuziemsky, Craig E. & O'Sullivan, Tracey L., 2015. "A model for common ground development to support collaborative health communities," Social Science & Medicine, Elsevier, vol. 128(C), pages 231-238.
    12. Driouchi, Ahmed, 2015. "New Health Technologies and Health Workforce in Developing Economies," MPRA Paper 67775, University Library of Munich, Germany.
    13. Clemens Blümel, 2018. "Translational research in the science policy debate: a comparative analysis of documents," Science and Public Policy, Oxford University Press, vol. 45(1), pages 24-35.
    14. Sang-Min Park & Nicholas S. Vonortas, 2023. "Translational research: from basic research to regional biomedical entrepreneurship," Small Business Economics, Springer, vol. 60(4), pages 1761-1783, April.
    15. Embrett, Mark G. & Randall, G.E., 2014. "Social determinants of health and health equity policy research: Exploring the use, misuse, and nonuse of policy analysis theory," Social Science & Medicine, Elsevier, vol. 108(C), pages 147-155.
    16. Claudimar Pereira Da Veiga & Cássia Rita Pereira Da Veiga & Jansen Maia Del Corso & Wesley Vieira Da Silva, 2015. "Dengue Vaccines: A Perspective from the Point of View of Intellectual Property," IJERPH, MDPI, vol. 12(8), pages 1-21, August.
    17. Herberholz, Chantal & Supakankunti, Siripen, 2015. "Contracting private hospitals: Experiences from Southeast and East Asia," Health Policy, Elsevier, vol. 119(3), pages 274-286.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:121:y:2017:i:7:p:745-754. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.